NCT03109717View on ClinicalTrials.gov

Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

May 31, 2021

Conditions
Treatment Resistant Depression
Interventions
DRUG

Monoamine Oxidase Inhibitor (MAOI)

Monoamine Oxidase Inhibitor

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

Kathryn O'Connor

OTHER

NCT03109717 - Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter